The newspapers are filled with mishandled mergers. Selecting the right company in which to invest in or acquire is a risky decision. You must rapidly and cost effectively evaluate new medical device ideas and the management running the companies. The medical industry presents an additional set of unique challenges. Assessing the viability of a medical device manufacturer requires regulatory and compliance experience and a specific skill set to make informed investment decisions. Not understanding the target company’s regulatory standing may mean long delays to market, recalls, or fines, that damage the value of the investment.
At MEDIcept, we have the expertise and experience to help investors make the right decision and maximize return on investment. We understand regulatory and clinical strategies, and what it takes to get a medical product to market – we work with these companies everyday. We have assessed investments for companies with a combined value of over $800 million.
Our due diligence assessment and analysis program can include:
- National and international regulatory strategy
- Product classification
- GLP/QSR/GMP compliance
- Marketing compliance
- Product labeling compliance
- Clinical evaluation reports